Beloteca is pleased to announce that it's CEO, Fred Defesche, was interviewed in CEO/CFO Magazine. To find the interview click here.
Beloteca, Inc.Beloteca, Inc. develops and obtains regulatory approval sterile pharmaceutical products. Our focus is on generic and 505(b)(2) reformulations. We target niche or difficult to manufacture products. Our focus is to outlicense these products to marketing partners. Archives |
RSS Feed